Cubicin and Abdominal pain - a phase IV clinical study of FDA data

Summary:

Abdominal pain is reported as a side effect among people who take Cubicin (daptomycin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Protonix, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Abdominal pain when taking Cubicin. It is created by eHealthMe based on reports of 7,953 people who have side effects when taking Cubicin from the FDA, and is updated regularly.

What is Cubicin?

Cubicin has active ingredients of daptomycin. It is often used in infection. eHealthMe is studying from 7,991 Cubicin users. Check the latest studies of Cubicin.

What is Abdominal pain?

Abdominal pain is found to be associated with 3,218 drugs and 5,756 conditions by eHealthMe. Check the latest studies of Abdominal pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 31, 2026

7,953 people reported to have side effects when taking Cubicin.
Among them, 35 people (0.44%) have Abdominal pain.

Among these 35 people:

How long have people been on Cubicin when they have Abdominal pain? *

What is the gender of people who have Abdominal pain when taking Cubicin? *

female: 78.79 %
male: 21.21 %

What is the age of people who have Abdominal pain when taking Cubicin? *

What are other drugs people take besides Cubicin? *

What are other side effects people have besides Abdominal pain? *

Fever: 18 people, 51.43%
Swelling: 10 people, 28.57%
Thrombocytopenia (decrease of platelets in blood): 10 people, 28.57%
Nausea And Vomiting: 10 people, 28.57%
Nausea (feeling of having an urge to vomit): 9 people, 25.71%
Rashes (redness): 8 people, 22.86%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 8 people, 22.86%
Anaemia (lack of blood): 8 people, 22.86%
Dyspnea (difficult or laboured breathing): 8 people, 22.86%
Swallowing Difficulty: 8 people, 22.86%

What are the existing conditions these people have? *

Osteomyelitis (infection of bone): 4 people, 11.43%
Cough: 4 people, 11.43%
Metastases To Bone (cancer spreads to bone): 4 people, 11.43%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 11.43%
Breast Cancer Metastatic: 4 people, 11.43%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 8.57%
Enterococcal Infection: 3 people, 8.57%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 8.57%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 3 people, 8.57%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Cubicin and have Abdominal pain?

- Check whether Abdominal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cubicin:

Cubicin (7,991 reports)

Abdominal pain treatments and more:

Abdominal pain (286,410 reports)

Browse all side effects of Cubicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain:

Abdominal pain (3,218 drugs)

Browse all the conditions that are associated with Abdominal pain:

Abdominal pain (5,756 conditions)

Related publications that referenced our studies

Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on daptomycin (the active ingredients of Cubicin) and Cubicin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.